Potential Value of Identifying Type 2 Diabetes Subgroups for Guiding Intensive Treatment: A Comparison of Novel Data-Driven Clustering With Risk-Driven Subgroups.
Journal article
Li X. et al, (2023), Diabetes Care
Estimating the Economic Value of Automated Virtual Reality Cognitive Therapy for Treating Agoraphobic Avoidance in Patients With Psychosis: Findings From the gameChange Randomized Controlled Clinical Trial.
Journal article
Altunkaya J. et al, (2022), Journal of medical Internet research, 24
Rehabilitation versus surgical reconstruction for non-acute anterior cruciate ligament injury (ACL SNNAP): a pragmatic randomised controlled trial.
Journal article
Beard DJ. et al, (2022), Lancet, 400, 605 - 615
The WISDOM self-management intervention: a cost-effectiveness analysis to support the transformation of type 2 diabetes care in England.
Journal article
Singh S. et al, (2022), Diabet Med
Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double-blind, placebo-controlled trial.
Journal article
Leal J. et al, (2022), Journal of diabetes, 14, 455 - 464
Hospital costs associated with adverse events in people with diabetes in the UK.
Journal article
Keng MJ. et al, (2022), Diabetes Obes Metab
The Potential Value of Clustering-Based Type 2 Diabetes Subgroups for Guiding Intensive Treatment: A Maximum Cost-Based Comparison with Threshold-Based Classifications
Conference paper
Li X. et al, (2022), DIABETES, 71
ACL Surgery Necessity in Non-Acute Patients (ACL SNNAP): a statistical analysis plan for a randomised controlled trial.
Journal article
Stokes JR. et al, (2022), Trials, 23
The transferability and validity of a population-level simulation model for the economic evaluation of interventions in diabetes: the MICADO model.
Journal article
Emamipour S. et al, (2022), Acta Diabetol
Efficacy of Liposomal Bupivacaine and Bupivacaine Hydrochloride vs Bupivacaine Hydrochloride Alone as a Periarticular Anesthetic for Patients Undergoing Knee Replacement: A Randomized Clinical Trial.
Journal article
Hamilton TW. et al, (2022), JAMA Surg
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analyses.
Journal article
Freeman D. et al, (2022), Lancet Psychiatry
Health-related quality of life for normal glycaemia, prediabetes and type 2 diabetes mellitus: Cross-sectional analysis of the ADDITION-PRO study.
Journal article
Leal J. et al, (2022), Diabet Med
Costs of Joint Replacement in Osteoarthritis: A Study Using the National Joint Registry and Clinical Practice Research Datalink Data Sets.
Journal article
Leal J. et al, (2022), Arthritis Care Res (Hoboken), 74, 392 - 402
Decrements in health-related quality of life associated with adverse events in people with diabetes.
Journal article
Keng MJ. et al, (2022), Diabetes Obes Metab, 24, 530 - 538
Cost-effectiveness of home-based stroke rehabilitation across Europe: A modelling study.
Journal article
Candio P. et al, (2022), Health Policy
Clinical and Cost-Effectiveness of Liposomal Bupivacaine and Bupivacaine Hydrochloride vs. Bupivacaine Hydrochloride alone as Peri-Articular Anaesthetic for Replacement of the Knee
Journal article
HAMILTON T. et al, (2022), JAMA Surgery
Impact of adverse events on hospital costs and health-related quality of life in people with diabetes
Other
Keng MJ. et al, (2022), DIABETES RESEARCH AND CLINICAL PRACTICE, 186
Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes Quality-of-Life Challenge.
Journal article
Tew M. et al, (2021), Med Decis Making
Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: a cost-utility analysis based on the EXSCEL trial.
Journal article
Becker F. et al, (2021), Diabetes Res Clin Pract
Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort
Journal article
Keng MJ. et al, (2021), Value in Health